Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-up Study on the Refobacin Revision-3 Bone Cement and Its Instrumentation

NCT06699160 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT06699160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-up Study on the Refobacin Revision-3 Bone Cement and Its Instrumentation
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Withdrawn
Start date
August 31, 2025
Completion date
December 31, 2030
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

revision arthroplasty